AI-Enhanced Cellular Modeling and Simulation for Multi-Scale Data Fusion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cellular modeling techniques struggle to integrate diverse data types, simulate across multiple scales, adapt to real-time data, and capture the complexity of biological systems, particularly in heterogeneous cell populations and dynamic microenvironments, limiting their ability to predict individual patient responses and design personalized treatments.

Innovation Solution

An AI-enhanced cellular modeling and simulation platform that integrates multi-omics data, imaging information, and clinical data using advanced AI and machine learning, enabling real-time data processing and compatibility with quantum computing to create comprehensive, dynamic models across multiple scales.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional cellular modeling techniques are used, then model simplicity and ease of implementation are maintained, but the ability to integrate diverse data types and capture biological system complexity is limited

Engineering Contradiction:
Improveability to integrate diverse data typesVSAvoidmodel complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system segments the cellular modeling process into distinct computational modules: differential equation solvers for biochemical reactions, agent-based models for cell-cell interactions, and spatial simulation components. Each module handles specific data types and biological processes independently, then integrates results through a unified framework, enabling diverse data integration without overwhelming system complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs composite modeling approaches by combining multiple modeling paradigms (differential equations, agent-based models, statistical methods) into a hybrid framework. This composite structure allows the system to leverage the strengths of each approach for different biological phenomena while maintaining overall model coherence and manageability

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If detailed single cell models are used, then cellular-level precision is improved, but the ability to simulate tissue-level and organism-level phenomena is limited

Engineering Contradiction:
Improvecellular behavior prediction accuracyVSAvoidmulti-scale simulation capability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The system implements nested modeling where single-cell models are embedded within tissue-level models, which are in turn embedded within organism-level models. Each scale operates with appropriate detail and complexity, with finer-scale models providing detailed mechanisms that feed into coarser-scale models for tissue and organism predictions, enabling precise cellular modeling while maintaining multi-scale versatility

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The patent adds the spatial and temporal dimensions to connect cellular-level detailed models with tissue-level phenomena. By incorporating spatial coordinates, time progression, and environmental context as additional dimensions, the system bridges the gap between microscopic cellular behavior and macroscopic tissue responses without sacrificing precision at any scale

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If static models are used, then model stability and computational efficiency are maintained, but the ability to adapt to real-time biological data is lost

Engineering Contradiction:
Improvemodel stabilityVSAvoidreal-time data adaptation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The system transitions from static to dynamic modeling by implementing time-dependent differential equations that continuously evolve based on current cellular states and incoming experimental data. The model parameters and structures can dynamically adjust as new biological data becomes available, maintaining stability through controlled adaptation mechanisms while capturing real-time biological variability

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent incorporates feedback loops where model predictions are continuously compared with experimental observations, and discrepancies feed back into model parameter adjustments. This feedback mechanism allows the system to maintain reliability through self-correction while adapting to real-time biological data, balancing model stability with dynamic responsiveness

Inventive Principle:
Principle #23Feedback

4Productivity

If conventional modeling frameworks are used, then computational resources are conserved, but the ability to process large-scale omics data and perform personalized medicine applications is limited

Engineering Contradiction:
Improvedata processing capabilityVSAvoidcomputational resource consumption
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The system performs preliminary data processing and feature extraction from omics data before main simulation execution. By pre-processing large-scale datasets to extract relevant features and reduce dimensionality beforehand, the system enables high-productivity personalized medicine applications while minimizing computational resource consumption during actual simulations through optimized input data structures

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250259715A1System and methods for ai-enhanced cellular modeling and simulation
Publication Date: 2025.08.14 QOMPLX INC
  • US20250259715A1 patent drawing
  • US20250259715A1 patent drawing
  • US20250259715A1 patent drawing

AI summary

The AI-enhanced cellular modeling and simulation platform is a computational system designed to enhance biomedical research and development and personalized medicine and wellness. This platform integrates simulation modeling, machine learning and artificial intelligence, multi-omics data, and sophisticated data fusion and decision-support techniques to create comprehensive models of cellular systems and processes across multiple scales. It enables researchers and clinicians to simulate complex biological interactions, predict disease progression, and design or optimize treatment strategies or medical devices with improved accuracy and efficacy. The system's architecture allows for integration of various components, including real-time data processing, federated learning, and quantum computing enhancements. From personalized drug discovery and cancer therapies to synthetic biology and epidemiological analysis, this platform offers powerful tools for understanding and manipulating cellular systems and bioengineered systems. By bridging the gap between molecular-level interactions between cells and materials and organism-wide effects, it enables significant advancements in healthcare and biological sciences.